Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors Meeting Abstract
| Authors: | Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; Abdel-Wahab, O.; Levine, R. L.; Viny, A. D.; Stein, E. M.; Roshal, M.; Tallman, M. S.; Goldberg, A. D. |
| Abstract Title: | Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205603240 |
| DOI: | 10.1182/blood-2020-137815 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 47 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
